244 related articles for article (PubMed ID: 15838934)
1. Enhancing rAAV vector expression in the lung.
Virella-Lowell I; Zusman B; Foust K; Loiler S; Conlon T; Song S; Chesnut KA; Ferkol T; Flotte TR
J Gene Med; 2005 Jul; 7(7):842-50. PubMed ID: 15838934
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of a recombinant adeno-associated virus 5-pseudotyped cystic fibrosis transmembrane conductance regulator vector.
Sirninger J; Muller C; Braag S; Tang Q; Yue H; Detrisac C; Ferkol T; Guggino WB; Flotte TR
Hum Gene Ther; 2004 Sep; 15(9):832-41. PubMed ID: 15353038
[TBL] [Abstract][Full Text] [Related]
3. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors.
Müller OJ; Leuchs B; Pleger ST; Grimm D; Franz WM; Katus HA; Kleinschmidt JA
Cardiovasc Res; 2006 Apr; 70(1):70-8. PubMed ID: 16448634
[TBL] [Abstract][Full Text] [Related]
4. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
5. An efficient rHSV-based complementation system for the production of multiple rAAV vector serotypes.
Kang W; Wang L; Harrell H; Liu J; Thomas DL; Mayfield TL; Scotti MM; Ye GJ; Veres G; Knop DR
Gene Ther; 2009 Feb; 16(2):229-39. PubMed ID: 18923452
[TBL] [Abstract][Full Text] [Related]
6. Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts.
Loiler SA; Tang Q; Clarke T; Campbell-Thompson ML; Chiodo V; Hauswirth W; Cruz P; Perret-Gentil M; Atkinson MA; Ramiya VK; Flotte TR
Mol Ther; 2005 Sep; 12(3):519-27. PubMed ID: 15979413
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
[TBL] [Abstract][Full Text] [Related]
8. Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice.
Rivière C; Danos O; Douar AM
Gene Ther; 2006 Sep; 13(17):1300-8. PubMed ID: 16688207
[TBL] [Abstract][Full Text] [Related]
9. [Gene transfer efficiencies and cell tropism of recombinant adeno-associated virus in the hippocampus of adult rat].
L i SF; Li ZJ; Li GL; Dou WC; Zhang ZX; Wei JJ; Kong YG; Xu L; Gao J; Wang RZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):512-6. PubMed ID: 16995303
[TBL] [Abstract][Full Text] [Related]
10. Controlled delivery of glial cell line-derived neurotrophic factor by a single tetracycline-inducible AAV vector.
Chtarto A; Yang X; Bockstael O; Melas C; Blum D; Lehtonen E; Abeloos L; Jaspar JM; Levivier M; Brotchi J; Velu T; Tenenbaum L
Exp Neurol; 2007 Mar; 204(1):387-99. PubMed ID: 17223106
[TBL] [Abstract][Full Text] [Related]
11. Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain.
Paterna JC; Moccetti T; Mura A; Feldon J; Büeler H
Gene Ther; 2000 Aug; 7(15):1304-11. PubMed ID: 10918501
[TBL] [Abstract][Full Text] [Related]
12. [Gene transfer patterns and transduction efficacy of recombinant adeno-associated virus type 1, 2, and 5 in brain: an experiment with rats].
Li SF; Wang RZ; Xu L; Zhang ZX; Li GL; Dou WC; Yin J; Yao Y
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(31):2196-200. PubMed ID: 16321184
[TBL] [Abstract][Full Text] [Related]
13. Recombinant AAV-mediated gene delivery to the central nervous system.
Tenenbaum L; Chtarto A; Lehtonen E; Velu T; Brotchi J; Levivier M
J Gene Med; 2004 Feb; 6 Suppl 1():S212-22. PubMed ID: 14978764
[TBL] [Abstract][Full Text] [Related]
14. Improved neuronal transgene expression from an AAV-2 vector with a hybrid CMV enhancer/PDGF-beta promoter.
Wang CY; Guo HY; Lim TM; Ng YK; Neo HP; Hwang PY; Yee WC; Wang S
J Gene Med; 2005 Jul; 7(7):945-55. PubMed ID: 15756650
[TBL] [Abstract][Full Text] [Related]
15. Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors.
Doll RF; Crandall JE; Dyer CA; Aucoin JM; Smith FI
Gene Ther; 1996 May; 3(5):437-47. PubMed ID: 9156805
[TBL] [Abstract][Full Text] [Related]
16. Efficient CFTR expression from AAV vectors packaged with promoters--the second generation.
Wang D; Fischer H; Zhang L; Fan P; Ding RX; Dong J
Gene Ther; 1999 Apr; 6(4):667-75. PubMed ID: 10476227
[TBL] [Abstract][Full Text] [Related]
17. Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain.
Wang C; Wang CM; Clark KR; Sferra TJ
Gene Ther; 2003 Aug; 10(17):1528-34. PubMed ID: 12900769
[TBL] [Abstract][Full Text] [Related]
18. Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.
Sumner-Jones SG; Davies LA; Varathalingam A; Gill DR; Hyde SC
Gene Ther; 2006 Dec; 13(24):1703-13. PubMed ID: 16855618
[TBL] [Abstract][Full Text] [Related]
19. Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice.
Song S; Goudy K; Campbell-Thompson M; Wasserfall C; Scott-Jorgensen M; Wang J; Tang Q; Crawford JM; Ellis TM; Atkinson MA; Flotte TR
Gene Ther; 2004 Jan; 11(2):181-6. PubMed ID: 14712302
[TBL] [Abstract][Full Text] [Related]
20. Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery.
Liqun Wang R; McLaughlin T; Cossette T; Tang Q; Foust K; Campbell-Thompson M; Martino A; Cruz P; Loiler S; Mueller C; Flotte TR
Mol Ther; 2009 Jan; 17(1):81-7. PubMed ID: 18941444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
